- Investing Ideas
- /
- Egyptian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Egyptian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
2
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
2 companies
Alexandria For Pharmaceuticals & Chemical Industries
Market Cap: ج.م2.2b
Manufactures, markets, and distributes generic forms of human and animal health products in Egypt.
AXPH
ج.م431.20
7D
0%
1Y
97.0%
Arab Drug
Market Cap: ج.م1.0b
Engages in the manufacture and sale of pharmaceutical products.
ADCI
ج.م173.17
7D
0.7%
1Y
115.4%